The first tri-party executive roundtable was held in London to strengthen synergies for Seegene's vision of creating 'a world free from diseases' - Preliminary results of product development ...
Due to their simplicity of collection and capacity to yield extensive diagnostic information, blood specimens now dominate the global immunoassay market. Adoption in therapeutic settings rises as a ...
BlueMark, a leading independent impact verification and intelligence provider for the impact and sustainable investing markets, today introduced a new rating system for impact investors called the ...
Mechelen, Belgium, 23 October 2024 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that six ... potentially due to a higher sensitivity than the ...